Theravance Biopharma Announced Transfer or Voluntary Withdrawal of Listing
On September 23, 2026, the company notified Nasdaq of the merger closing and requested suspension of trading as of the close of business that day, and that Nasdaq file a Form 25 to delist and deregister its ordinary shares. The delisting will be effective 10 days after the Form 25 is filed, after w…